Encyclia Pharmaceuticals Private Limited

Encyclia Pharmaceuticals Private Limited - education in Delhi, India. FY 2026 financials & compliance.
CIN U80100DL2012PTC244482 Incorporated 05 November 2012 ROC Delhi HQ Delhi, India
Active Private Limited Company education MSME · Micro
Revenue · FY 2024
₹10,000
▼ 100% YoY
Net loss · FY 2024
₹13.91 Lakh
Latest filing
EBITDA · FY 2024
-₹5.69 Lakh
Latest filing
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹18 Lakh
Issued & subscribed
Open charges
₹20.2 Lakh
Satisfied ₹50 Lakh
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings

About Encyclia Pharmaceuticals Private Limited

Data last updated:

Encyclia Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the corporate training and development segment of the education sector. It was incorporated on 05 November 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U80100DL2012PTC244482. Its GSTIN is 07AADCE2147A1Z9 (Delhi). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹18 Lakh. It was formerly known as Encyclia Private Limited and Excalibur Learning Private Limited. It is led by directors Atish Kumar and Koushlia Devi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, India – 110060.

As per the financials filed for FY 2024, the company reported a revenue of ₹10,000, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹13.91 Lakh and EBITDA of -₹5.69 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 72% over three years and 63% over five years.

As per MCA filings, the company has open charges of ₹20.2 Lakh and satisfied charges of ₹50 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it.

Encyclia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0001973). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website exlp.net.

Company details

CIN U80100DL2012PTC244482
Registration Number 244482
Incorporation Date 05 November 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0001973

Name history

Encyclia Pharmaceuticals has undergone 4 name changes throughout its history. The current legal name is Encyclia Pharmaceuticals Private Limited.

Company NameStatus
Encyclia Pharmaceuticals Private LimitedCurrent
Encyclia Private LimitedPrevious
Excalibur Learning Private LimitedPrevious
Excalibur Infradevelopers Private LimitedPrevious
Encyclia Global Private LimitedPrevious

CIN history

Encyclia Pharmaceuticals has one previous CIN (Corporate Identification Number): U45400DL2012PTC244482. The current CIN is U80100DL2012PTC244482, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U80100DL2012PTC244482Current
U45400DL2012PTC244482Previous

Recognitions & Rankings of Encyclia Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-01-0001973

Contact details

Encyclia Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is exlp.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, India – 110060
  • Industry
    Education, Corporate Training & Development

To see the full contact details of Encyclia Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Encyclia Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Encyclia Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Encyclia Pharmaceuticals Private Limited, buy the company report.

Financials of Encyclia Pharmaceuticals Private Limited

FY 2025 filings available

Encyclia Pharmaceuticals Private Limited reported revenue of ₹10,000 (down 100% YoY) for FY 2024.

Revenue · FY 2024
₹10,000 ▼ 100%
Net loss · FY 2024
₹13.91 Lakh
EBITDA · FY 2024
-₹5.69 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 72%
5 years · compounded
▼ 63%
EBITDA CAGR growth
1 year
▼ 168%
3 years · compounded
▲ 31%
5 years · compounded
▼ 20%

Revenue has declined at a compounded annual rate (CAGR) of 63% over five years. EBITDA fell 168% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹5.69 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Encyclia Pharmaceuticals Private Limited, buy the company report.

Board of directors of Encyclia Pharmaceuticals Private Limited

Encyclia Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Koushlia DeviAdditional Director18 Aug 20233 Years 3 MonthsCurrent
Atish KumarDirector05 Nov 201214 Years 0 MonthsCurrent

Auditor

Encyclia Pharmaceuticals Private Limited is audited by ANKIT ANIL & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
ANKIT ANIL & ASSOCIATESFY 2019026702N

Shareholding

The shareholding of Encyclia Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Encyclia Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹20.2 Lakh
Satisfied charges
₹50 Lakh
Breakdown by lending institutions
Others₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 May 2019100269635Others₹20.2 LakhOpen
04 Mar 201310414977Punjab National Bank₹50 LakhSatisfied

To see the full charge records of Encyclia Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Encyclia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Encyclia Pharmaceuticals has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AADCE2147A1Z9DelhiActive19 Aug 2017
07AADCE2147A2Z8DelhiActive27 Jan 2020
09AADCE2147A2Z4Uttar PradeshActive12 Sep 2020

To see the full GST registrations and return filing status of Encyclia Pharmaceuticals Private Limited, buy the company report.

Recent activity

Encyclia Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Adesh Kumar ceased to be Additional Director on 23 Aug 2023.

AGM
Encyclia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Encyclia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Adesh Kumar ceased to be Additional Director.
Appointed
Koushlia Devi was appointed as Additional Director.
Ceased
Pramod ceased to be Director.
Charges
A charge with Others amounted to Rs. 20.20 Lakh with Charge ID 100269635 was registered on 27 May 2019.
Charges
A charge registered on 04 Mar 2013 via Charge ID 10414977 with Punjab National Bank was fully satisfied on 24 Mar 2017.
Charges
A charge with Punjab National Bank amounted to Rs. 50.00 Lakh with Charge ID 10414977 was registered on 04 Mar 2013.
Appointed
Atish Kumar was appointed as Director.
Incorporation
05 Nov 2012
Encyclia Pharmaceuticals Private Limited was registered on 05 Nov 2012 with Roc Delhi I & aged 14 years 13 days as per MCA records.

Frequently asked questions

Encyclia Pharmaceuticals is an active private limited company based in Delhi, India. The company works in corporate training and development, within the education industry. It was incorporated on 05 November 2012 (14+ years old) and is registered under CIN U80100DL2012PTC244482.

Encyclia Pharmaceuticals has 2 current directors:

The latest financial statements of Encyclia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Encyclia Pharmaceuticals is 07AADCE2147A1Z9, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AADCE2147A2Z8 (Delhi), 09AADCE2147A2Z4 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Encyclia Pharmaceuticals is U80100DL2012PTC244482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Encyclia Pharmaceuticals has 3 court cases on record: 3 filed against it.

Encyclia Pharmaceuticals was incorporated on 05 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.

Adesh Kumar ceased to be Additional Director on 23 Aug 2023. Koushlia Devi was appointed as Additional Director on 18 Aug 2023. Pramod ceased to be Director on 12 Dec 2019. Encyclia Pharmaceuticals has 4 board changes on record in total.

Yes, Encyclia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0001973).

Encyclia Pharmaceuticals can be reached through the website exlp.net. Its registered office is in Delhi, India.